Fig. 4From: Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS): a double-blind randomised placebo-controlled crossover trialSecondary inducible ischaemia endpoints. a Time to 0.1Â mV ST-segment depression ETT-1 placebo vs. ETT-3 1.2Â mg liraglutide. b Time to 0.1Â mV ST-segment depression ETT-2 placebo vs. ETT-4 1.8Â mg liraglutide. c Time to maximum ST-segment depression ETT-1 placebo vs. ETT-3 1.2Â mg liraglutide. d Time to maximum ST-segment depression ETT-2 placebo vs. ETT-4 1.8Â mg liraglutideBack to article page